Corvus Pharmaceuticals
CRVS
#8137
Rank
C$0.27 B
Marketcap
$4.05
Share price
-4.68%
Change (1 day)
77.00%
Change (1 year)

Earnings for Corvus Pharmaceuticals (CRVS)

Earnings in 2024 (TTM): -C$85.27 Million

According to Corvus Pharmaceuticals 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -C$38.43 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corvus Pharmaceuticals from 2015 to 2024

Annual earnings

Year Earnings Change
2024 -C$88.56 Million130.47%
2023 -C$38.43 Million-34.57%
2022 -C$58.73 Million-4.47%
2021 -C$61.48 Million621.28%
2020 -C$8.53 Million-87.16%
2019 -C$66.35 Million-0.57%
2018 -C$66.73 Million-15.67%
2017 -C$79.14 Million53.03%
2016 -C$51.72 Million16.08%
2015 -C$44.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.21 Billion 129.39%๐Ÿ‡บ๐Ÿ‡ธ USA